Arterial Blood Gas Analysis in Laparoscopic Cholecystectomy
NCT ID: NCT03133494
Last Updated: 2017-05-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2015-04-01
2016-04-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Hemodynamic Changes Caused by Different Pneumoperitoneum Pressure Ranges (10-12 mmHg and 13- 15 mmHg ) on Cerebral Oxygenation (With a Non-invasive Technique, Near Infrared Spectroscopy (NIRS) ) in Laparoscopic Cholecystectomy
NCT04309318
Comparison of Systemic Response After Laparoscopies Performed With Standard and Low-Pressure Pneumoperitoneum
NCT00567125
Comparison Between Low Pressure Versus High Pressure Laparoscopic Cholecystectomy
NCT00606762
Diaphragmatic Excursion Changes and Postoperative Oxygenation After Laparoscopic Cholecystectomy
NCT07332728
Effect of Low-pressure Pneumoperitoneum on Pain and Inflammation in Laparoscopic Cholecystectomy
NCT05530564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tobacco smoking is an internationally accepted health hazard. The United nation (UN) health agency reports that about 4.9 million people die each year across the globe due to cigarette smoking. Chronic smoking (more than 20 pack year at least for 10 year) causes a number of pathological changes in respiratory system which includes inflammatory changes in lung parenchyma, imbalance between protease and anti-protease, oxidative stress, cilliary dysfunction, mucosal hyper secretion, airflow limitation and pulmonary hypertension.
Arterial blood gas analysis plays a very important role in assessing the acid-base status, adequacy of oxygenation and ventilation. It is very useful in management of critically ill patients and in patients with pulmonary disorders. It is also a standard part of work-up for the patients who present with unexplained hypoxemia and dyspnea. An ABG test uses blood drawn from an artery, where the oxygen and carbon dioxide levels can be measured before they enter body tissues.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SCREENING
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Laparoscopic cholecystectomy in smokers
ABG analysis of patients with history of smoking posted for laparoscopic cholecystectomy was collected
ABG analysis
ABG analysis was performed and compared between two groups
Laparoscopic cholecystectomy nonsmokers
ABG analysis of patients without history of smoking posted for laparoscopic cholecystectomy was collected
ABG analysis
ABG analysis was performed and compared between two groups
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ABG analysis
ABG analysis was performed and compared between two groups
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* History of smoking (more than 20 pack year) for more than 10years
Exclusion Criteria
* ASA grade 3 and 4
* Other lung pathologies
* Other cardiac pathologies
* uncontrolled diabetes mellitus
* systemic infection
* emergency operation
* history of malignancy
* history of alcohol or drug abuse
20 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Banaras Hindu University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amiya Kumar Barik
abarik, Final year resident, Department of Anesthesiology, Institute of Medical Sciences
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
PUSKAR RANJAN, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Banaras Hindu University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-15/EC/1219
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.